Argent Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-68,470
| Closed | -$2.27M | – | 205 |
|
|
2019
Q2 | $2.27M | Buy |
68,470
+1,250
| +2% | +$41.4K | 0.09% | 106 |
|
|
2019
Q1 | $2.36M | Sell |
67,220
-8,600
| -11% | -$301K | 0.09% | 97 |
|
|
2018
Q4 | $2.52M | Sell |
75,820
-150
| -0.2% | -$4.98K | 0.13% | 87 |
|
|
2018
Q3 | $3.83M | Hold |
75,970
| – | – | 0.13% | 77 |
|
|
2018
Q2 | $4.55M | Buy |
75,970
+6,205
| +9% | +$371K | 0.16% | 68 |
|
|
2018
Q1 | $3.2M | Buy |
69,765
+315
| +0.5% | +$14.4K | 0.12% | 88 |
|
|
2017
Q4 | $2.71M | Hold |
69,450
| – | – | 0.09% | 103 |
|
|
2017
Q3 | $2.78M | Sell |
69,450
-22,175
| -24% | -$887K | 0.11% | 98 |
|
|
2017
Q2 | $3.95M | Buy |
91,625
+2,675
| +3% | +$115K | 0.16% | 79 |
|
|
2017
Q1 | $2.78M | Buy |
88,950
+4,950
| +6% | +$155K | 0.11% | 99 |
|
|
2016
Q4 | $2.12M | Buy |
+84,000
| New | +$2.12M | 0.09% | 109 |
|